Blog

Overcoming Obstacles in the development of Live Biotherapeutic Products

August 18, 2021

By: admin

I’d like to tell you about some of the obstacles you may encounter as you develop your live biotherapeutic product (LBP) and how List Labs can help you navigate through them. Harnessing bacteria’s potential for a healthier world is our company mission.  Our history and experience have been devoted to bacteria – what bacteria can produce […]

March 19, 2021

By: admin

Botulinum Toxin Infographic  Diphtheria Toxin Infographic  Pertussis Toxin Infographic

December 2, 2020

By: admin

On May 14, 2020, a team spanning the University of California San Diego, San Francisco General Hospital, Cook County Health and Hospitals System in Chicago, and Washington University in St. Louis published a milestone study in the New England Journal of Medicine. Cohen et al demonstrated the effectiveness of LACTIN-V, a new Live Biotherapeutic Product […]

October 21, 2020

By: admin

The purity of your recombinant proteins is critical to the success of your research. A number of contaminants can affect both in vitro and in vivo systems. Some of the results are predictable, but others are not. All can affect your experimental data. This article will focus on one of the most common contaminants: endotoxins […]

Cholera Toxin

September 15, 2020

By: admin

The List Labs Citation Database is a robust tool for researchers. It offers thousands of papers showing how List Labs products are used experimentally. Researchers can search keywords specific to their fields of study and learn how others in that field have used our toxins and antigens. In this article, we will explore experimental applications […]

August 7, 2020

By: admin

  What is Coronavirus (COVID-19)? Coronavirus (COVID-19) is a disease caused by a virus (SARS-CoV-2) that can trigger what doctors call a respiratory tract infection, and is transmitted from person-to-person. What are the Symptoms of Coronavirus (COVID-19)? Coronavirus (COVID-19) symptoms can range from mild to severe. Though, elderly people and people with underlying health conditions […]